Drug
Ravagalimab clinical trials
Also written ABBV-323.
Keep track of what changes. Save the ravagalimab studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2019 (1)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses ravagalimab is read from its arms, and is right about nine times in ten.
Testing it · 4
- A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid ArthritisRecruitingPhase 2AbbVieNCT06972446Written as Ravagalimab
- A Study in Healthy Adult Participants to Assess the Pharmacokinetics, Immunogenicity, Safety, and Tolerability of a Ravagalimab Subcutaneous Formulation in a Pre-Filled SyringeCompletedPhase 1AbbVieNCT06402513Written as Ravagalimab
- A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior TherapyCompletedPhase 2AbbVieNCT03695185Written as Ravagalimab 600 mg
- An Efficacy and Safety Study of Injectable Ravagalimab to Assess Change in EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) in Adult Participants With Moderately to Severely Active Primary Sjogren's Syndrome (pSS)WithdrawnPhase 2AbbVieNCT05217472Written as Ravaglimab
Codes
What other systems call ravagalimab · ClinicalTrials.gg INT018596
- UNII (FDA) YGF9TW3QZJRAVAGALIMABOne source FDA
- NCI Thesaurus C170363RavagalimabOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | YGF9TW3QZJ | RAVAGALIMAB | One source FDA |
| NCI Thesaurus | C170363 | Ravagalimab | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.